• Market Intelligence Toolkit
  • Barriers To Entry Toolkit
  • Market Intelligence Library
Market Intelligence
  • For Suppliers
  • For Buyers, Investors & Primes
Products
  • Events and Webinars
  • Articles & News
Events
CUREVAC AG logo

CUREVAC AG

PSF Verified
Paul-Ehrlich-Str. 15, Tubingen 72076, Germany
DUNS #:
331005764
CAGE Code:
CG410
Type:
Unknown
Employees:
200-500
Annual Revenue:
$5M-$50M
Year Founded:
2000
Country of Origin:
Germany
Sectors Served:
US Federal, Private Sector
Company Security Level:
Unknown
Credit Card Usage:
Unknown

Specialties and Expertise:

Contact/Location Info3

Size and minority status

Size
Small business
Ownership
African American
Alaska Native
Asian-Indian
Asian-Pacific
Hispanic
Minority-Unspecified
Native American
Native Hawaiian
Tribal
Unspecified
Veteran
Woman
Government Set-Aside Programs
AbilityOne
HUBZone
SBA 8(a)
SDVOSB
Small Disadvantaged Business (SDB)
Woman Owned Small Business (WOSB)

Commodity Codes4

PRODUCTS AND SERVICES2

mRNA Technology
3 past experiences
Messenger RNA or mRNA transfer the instructions stored in DNA to make the proteins required in every living cell. The approach is to use mRNA medicines to instruct a patient's own cells to produce proteins that could prevent, treat, or cure disease.
CureVac Coronavirus Program
1 past experience
CureVac has started working on the development of an mRNA-based Coronavirus vaccine.

Past experience3

other
Development of mRNA-based Coronavirus Vaccine
CureVac provides mRNA-based drugs for vaccines and therapeutics, leveraging its potent vaccine platform to focus on developing a pot...
other
The RNA PrinterTM Prototype
CureVac with CEPI is developing The RNA PrinterTM prototype, an automated mRNA printing facility that can provide mRNA based vaccine...
other
Cancer Vaccine Products
Lilly and CureVac are on the development of up to five potential cancer vaccine products based on CureVac’s mRNA therapeutics to fig...

Known Locations Served2

My Notes
Contact
My Notes